Downregulation of miR-452 promotes stem-like traits and tumorigenicity of gliomas

Liping Liu, Kun Chen, Jueheng Wu, Ling Shi, Bo Hu, Shi-Yuan Cheng, Mengfeng Li, Libing Song*

*Corresponding author for this work

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Purpose: miR-452 is reported to be required for neural crest stem cell differentiation during neural crest development. However, the biologic role of miR-452 in gliomas remains unclear. The aim of the present study was to evaluate the effect of miR-452 on the stem-like properties and tumorigenesis of glioma cells. Experimental Design: The expression of miR-452 was examined in glioma cells and glioma tissues using real-time PCR. The effects of miR-452 on stem-like traits and tumorigenesis were investigated in vitro and in vivo using patient-derived glioma cells and glioma cell lines. Western blotting and luciferase reporter assays were conducted to examine the negative regulation of Bmi-1, LEF1, and TCF4 by miR-452. The methylation of the miR-452 promoter region was examined by bisulfite genomic sequencing PCR. Results: miR-452 was markedly downregulated in glioma cells and clinical glioma tissues. miR-452 levels were inversely correlated with World Health Organization (WHO) grades and patient survival. miR-452 directly targeted and suppressed multiple stemness regulators, including Bmi-1, LEF1, and TCF4, resulting in reduced stem-like traits and tumorigenesis of glioma cells in vitro and in vivo. Furthermore, we showed that downregulation of miR-452 in gliomas was caused by hypermethylation of its promoter region. Conclusions: Downregulation of miR-452 plays an important role in promoting the stem-like traits and tumorigenesis of gliomas and may represent a novel prognostic biomarker and therapeutic target for the disease.

Original languageEnglish (US)
Pages (from-to)3429-3438
Number of pages10
JournalClinical Cancer Research
Volume19
Issue number13
DOIs
StatePublished - Jul 1 2013

Fingerprint

Glioma
Down-Regulation
Carcinogenesis
Neural Crest
Genetic Promoter Regions
Neural Stem Cells
Luciferases
Methylation
Real-Time Polymerase Chain Reaction
Cell Differentiation
Research Design
Biomarkers
Western Blotting
Cell Line
Polymerase Chain Reaction
Survival

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Liu, Liping ; Chen, Kun ; Wu, Jueheng ; Shi, Ling ; Hu, Bo ; Cheng, Shi-Yuan ; Li, Mengfeng ; Song, Libing. / Downregulation of miR-452 promotes stem-like traits and tumorigenicity of gliomas. In: Clinical Cancer Research. 2013 ; Vol. 19, No. 13. pp. 3429-3438.
@article{a379796fe4d848ccb3a38e70f7822cb4,
title = "Downregulation of miR-452 promotes stem-like traits and tumorigenicity of gliomas",
abstract = "Purpose: miR-452 is reported to be required for neural crest stem cell differentiation during neural crest development. However, the biologic role of miR-452 in gliomas remains unclear. The aim of the present study was to evaluate the effect of miR-452 on the stem-like properties and tumorigenesis of glioma cells. Experimental Design: The expression of miR-452 was examined in glioma cells and glioma tissues using real-time PCR. The effects of miR-452 on stem-like traits and tumorigenesis were investigated in vitro and in vivo using patient-derived glioma cells and glioma cell lines. Western blotting and luciferase reporter assays were conducted to examine the negative regulation of Bmi-1, LEF1, and TCF4 by miR-452. The methylation of the miR-452 promoter region was examined by bisulfite genomic sequencing PCR. Results: miR-452 was markedly downregulated in glioma cells and clinical glioma tissues. miR-452 levels were inversely correlated with World Health Organization (WHO) grades and patient survival. miR-452 directly targeted and suppressed multiple stemness regulators, including Bmi-1, LEF1, and TCF4, resulting in reduced stem-like traits and tumorigenesis of glioma cells in vitro and in vivo. Furthermore, we showed that downregulation of miR-452 in gliomas was caused by hypermethylation of its promoter region. Conclusions: Downregulation of miR-452 plays an important role in promoting the stem-like traits and tumorigenesis of gliomas and may represent a novel prognostic biomarker and therapeutic target for the disease.",
author = "Liping Liu and Kun Chen and Jueheng Wu and Ling Shi and Bo Hu and Shi-Yuan Cheng and Mengfeng Li and Libing Song",
year = "2013",
month = "7",
day = "1",
doi = "10.1158/1078-0432.CCR-12-3794",
language = "English (US)",
volume = "19",
pages = "3429--3438",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "13",

}

Downregulation of miR-452 promotes stem-like traits and tumorigenicity of gliomas. / Liu, Liping; Chen, Kun; Wu, Jueheng; Shi, Ling; Hu, Bo; Cheng, Shi-Yuan; Li, Mengfeng; Song, Libing.

In: Clinical Cancer Research, Vol. 19, No. 13, 01.07.2013, p. 3429-3438.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Downregulation of miR-452 promotes stem-like traits and tumorigenicity of gliomas

AU - Liu, Liping

AU - Chen, Kun

AU - Wu, Jueheng

AU - Shi, Ling

AU - Hu, Bo

AU - Cheng, Shi-Yuan

AU - Li, Mengfeng

AU - Song, Libing

PY - 2013/7/1

Y1 - 2013/7/1

N2 - Purpose: miR-452 is reported to be required for neural crest stem cell differentiation during neural crest development. However, the biologic role of miR-452 in gliomas remains unclear. The aim of the present study was to evaluate the effect of miR-452 on the stem-like properties and tumorigenesis of glioma cells. Experimental Design: The expression of miR-452 was examined in glioma cells and glioma tissues using real-time PCR. The effects of miR-452 on stem-like traits and tumorigenesis were investigated in vitro and in vivo using patient-derived glioma cells and glioma cell lines. Western blotting and luciferase reporter assays were conducted to examine the negative regulation of Bmi-1, LEF1, and TCF4 by miR-452. The methylation of the miR-452 promoter region was examined by bisulfite genomic sequencing PCR. Results: miR-452 was markedly downregulated in glioma cells and clinical glioma tissues. miR-452 levels were inversely correlated with World Health Organization (WHO) grades and patient survival. miR-452 directly targeted and suppressed multiple stemness regulators, including Bmi-1, LEF1, and TCF4, resulting in reduced stem-like traits and tumorigenesis of glioma cells in vitro and in vivo. Furthermore, we showed that downregulation of miR-452 in gliomas was caused by hypermethylation of its promoter region. Conclusions: Downregulation of miR-452 plays an important role in promoting the stem-like traits and tumorigenesis of gliomas and may represent a novel prognostic biomarker and therapeutic target for the disease.

AB - Purpose: miR-452 is reported to be required for neural crest stem cell differentiation during neural crest development. However, the biologic role of miR-452 in gliomas remains unclear. The aim of the present study was to evaluate the effect of miR-452 on the stem-like properties and tumorigenesis of glioma cells. Experimental Design: The expression of miR-452 was examined in glioma cells and glioma tissues using real-time PCR. The effects of miR-452 on stem-like traits and tumorigenesis were investigated in vitro and in vivo using patient-derived glioma cells and glioma cell lines. Western blotting and luciferase reporter assays were conducted to examine the negative regulation of Bmi-1, LEF1, and TCF4 by miR-452. The methylation of the miR-452 promoter region was examined by bisulfite genomic sequencing PCR. Results: miR-452 was markedly downregulated in glioma cells and clinical glioma tissues. miR-452 levels were inversely correlated with World Health Organization (WHO) grades and patient survival. miR-452 directly targeted and suppressed multiple stemness regulators, including Bmi-1, LEF1, and TCF4, resulting in reduced stem-like traits and tumorigenesis of glioma cells in vitro and in vivo. Furthermore, we showed that downregulation of miR-452 in gliomas was caused by hypermethylation of its promoter region. Conclusions: Downregulation of miR-452 plays an important role in promoting the stem-like traits and tumorigenesis of gliomas and may represent a novel prognostic biomarker and therapeutic target for the disease.

UR - http://www.scopus.com/inward/record.url?scp=84879869302&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879869302&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-12-3794

DO - 10.1158/1078-0432.CCR-12-3794

M3 - Article

C2 - 23695168

AN - SCOPUS:84879869302

VL - 19

SP - 3429

EP - 3438

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 13

ER -